Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis.

Wolf, D

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. [electronic resource] - Alimentary pharmacology & therapeutics Sep 2014 - 486-97 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2036

10.1111/apt.12863 doi


Adalimumab
Adult
Anti-Inflammatory Agents--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Colitis, Ulcerative--drug therapy
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors